Skip to main content

Feds approve Regeneron, Sanofi skin cancer drug

Drug makers Regeneron Pharmaceuticals and Sanofi have won federal approval to make a skin cancer medication for patients who do not respond to surgery or radiation.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.